fluorouracil has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 55 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Fifty-five breast cancer patients treated with mitoxantrone, methotrexate and 5-fluorouracil gave a response rate of 52." | 5.06 | [Mitoxantrone containing multi-drug chemotherapy in the management of malignancies. Collaborative Group for Clinical Trial of Mitoxantrone]. ( , 1989) |
| "We reviewed published studies reporting phase II and III clinical trials of dose-dense regimens for breast cancer and NHL, TAC (docetaxel, adriamycin, cyclophosphamide) chemotherapy for breast cancer, and infusional 5-fluorouracil-based regimens for colorectal cancer." | 4.83 | Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer. ( Avritscher, EB; Bekele, BN; Cooksley, CD; Elting, LS; Jones, JA; Michelet, M, 2006) |
| "Chemotherapy programs using either bolus or infusional delivery were selected representing standard or commonplace regimens for the treatment of patients with breast cancer (cyclophosphamide, methotrexate, fluorouracil [CMF] or CA); colon cancer (5-fluorouracil[5-FU] infusion vs." | 3.69 | Comparison of costs for infusion versus bolus chemotherapy administration: analysis of five standard chemotherapy regimens in three common tumors--Part one. Model projections for cost based on charges. ( Anderson, NR; Lokich, JJ; Moore, CL, 1996) |
| "Treatment of both Hodgkin's disease (HD) and high-grade non-Hodgkin's lymphoma (HG-NHL) with bulky presentation at diagnosis frequently results in residual masses detected radiologically." | 2.68 | Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma. ( Babini, L; Barbieri, E; Battista, G; Bendandi, M; Canini, R; Fanti, S; Frezza, G; Gherlinzoni, F; Gozzetti, A; Merla, E; Monetti, N; Pisi, P; Rimondi, MR; Tura, S; Zinzani, PL; Zompatori, M, 1996) |
| "Transient hypotension was the most common side effect occurring in association with amifostine." | 1.31 | Tolerability of the cytoprotective agent amifostine in elderly patients receiving chemotherapy: a comparative study. ( Genvresse, I; Harder, H; Lange, C; Possinger, K; Schanz, J; Schweigert, M; Späth-Schwalbe, E, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 34 (61.82) | 18.7374 |
| 1990's | 16 (29.09) | 18.2507 |
| 2000's | 4 (7.27) | 29.6817 |
| 2010's | 1 (1.82) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ramachandran, S | 1 |
| Mandal, M | 1 |
| MACLEOD, RM | 1 |
| KING, CE | 1 |
| HOLLANDER, VP | 3 |
| KASBEKAR, DK | 1 |
| GREENBERG, DM | 1 |
| BOOTH, BA | 1 |
| SARTORELLI, AC | 1 |
| BRINDLEY, CO | 1 |
| MCBRIDE, TJ | 1 |
| NOBLE, LC | 1 |
| CARR, MA | 1 |
| HULL, K | 1 |
| OLESON, JJ | 1 |
| FALKSON, G | 1 |
| SNYMAN, HJ | 1 |
| KARNOFSKY, DA | 1 |
| MYHRE, K | 1 |
| FJAERLI, J | 1 |
| SULLIVAN, RD | 1 |
| ZUREK, WZ | 1 |
| Jones, JA | 1 |
| Avritscher, EB | 1 |
| Cooksley, CD | 1 |
| Michelet, M | 1 |
| Bekele, BN | 1 |
| Elting, LS | 1 |
| Damiani, D | 2 |
| Grimaz, S | 1 |
| Sperotto, A | 2 |
| Geromin, A | 2 |
| Skert, C | 1 |
| Cerno, M | 2 |
| Rinaldi, C | 2 |
| Fanin, R | 2 |
| Kumazawa, H | 1 |
| Imai, N | 1 |
| Shioya, M | 1 |
| Kato, K | 1 |
| Fukaya, Y | 1 |
| Noguchi, A | 1 |
| Rakhimov, KD | 1 |
| Vermenichev, SM | 1 |
| Kabiev, OK | 1 |
| Mazza, P | 2 |
| Zinzani, PL | 6 |
| Martelli, M | 9 |
| Fiacchini, M | 3 |
| Bocchia, M | 3 |
| Pileri, S | 3 |
| Falini, B | 1 |
| Martelli, MF | 2 |
| Amadori, S | 7 |
| Papa, G | 7 |
| Ghoshal, K | 1 |
| Jacob, ST | 1 |
| Vignetti, M | 1 |
| Gherlinzoni, F | 5 |
| Meloni, G | 1 |
| De Sanctis, V | 1 |
| Calabresi, F | 1 |
| Tura, S | 5 |
| Mandelli, F | 9 |
| Lokich, JJ | 2 |
| Moore, CL | 2 |
| Anderson, NR | 2 |
| Zompatori, M | 1 |
| Bendandi, M | 3 |
| Battista, G | 1 |
| Fanti, S | 1 |
| Barbieri, E | 1 |
| Rimondi, MR | 1 |
| Frezza, G | 1 |
| Pisi, P | 1 |
| Merla, E | 1 |
| Gozzetti, A | 1 |
| Canini, R | 1 |
| Monetti, N | 1 |
| Babini, L | 1 |
| Gorbunov, GF | 1 |
| Silvestri, F | 1 |
| Infanti, L | 1 |
| Stocchi, R | 1 |
| Savignano, C | 1 |
| Baccarani, M | 1 |
| Buzzi, M | 1 |
| Sabattini, E | 1 |
| Ascani, S | 1 |
| Magagnoli, M | 2 |
| Albertini, P | 1 |
| Zaja, F | 1 |
| Storti, S | 1 |
| Pavone, E | 1 |
| Lauta, VM | 1 |
| De Renzo, A | 1 |
| Gobbi, M | 1 |
| Ronconi, F | 1 |
| Scaramucci, L | 1 |
| Palombi, F | 1 |
| Stefoni, V | 1 |
| Anticoli Borza, P | 1 |
| Cellini, C | 1 |
| Messori, A | 1 |
| Vaiani, M | 1 |
| Trippoli, S | 1 |
| Rigacci, L | 1 |
| Jerkeman, M | 1 |
| Longo, G | 1 |
| Genvresse, I | 1 |
| Lange, C | 1 |
| Schanz, J | 1 |
| Schweigert, M | 1 |
| Harder, H | 1 |
| Possinger, K | 1 |
| Späth-Schwalbe, E | 1 |
| Garibjanian, BT | 1 |
| Johnson, RK | 1 |
| Kline, I | 1 |
| Vadlamudi, S | 1 |
| Gang, M | 1 |
| Venditti, JM | 1 |
| Goldin, A | 1 |
| Mokka, RE | 1 |
| Larmi, TK | 1 |
| Huttunen, R | 1 |
| Kairaluoma, MI | 1 |
| Iaremenko, KV | 1 |
| Kharitonenko, TS | 1 |
| Golubeva, TA | 1 |
| Guglielmi, C | 6 |
| Todeschini, G | 1 |
| Ambrosetti, A | 1 |
| Meneghini, V | 1 |
| Pizzolo, G | 1 |
| Menestrina, F | 1 |
| Chilosi, M | 1 |
| Benedetti, F | 1 |
| Veneri, D | 1 |
| Cetto, GL | 1 |
| Perona, G | 1 |
| Coluzzi, S | 1 |
| Dragoni, F | 1 |
| Jin, BL | 1 |
| Ruco, LP | 1 |
| Mantovani, L | 1 |
| Jarczok, K | 1 |
| Kardaszewicz, S | 1 |
| Luciak, M | 1 |
| Kubińska, E | 1 |
| Huzarski, J | 1 |
| Anselmo, AP | 1 |
| Baroni, CD | 1 |
| Biagini, C | 1 |
| Cimino, G | 1 |
| Nishimawari, K | 1 |
| Gribel', NV | 1 |
| Pashinskiĭ, VG | 1 |
| Hedley, DW | 1 |
| Gary-Bobo, J | 1 |
| Armstrong, JG | 1 |
| Knock, FE | 1 |
| Galt, RM | 1 |
| Oester, YT | 1 |
| Sylvester, R | 1 |
| Kessel, D | 1 |
| Dodd, DC | 1 |
| Hall, TC | 1 |
| Alberto, P | 1 |
| Burdette, WJ | 1 |
| Stutzman, L | 1 |
| Pol'kina, RI | 1 |
| Nelson, RS | 1 |
| Lanza, FL | 1 |
| Mashburn, LT | 1 |
| Ambellian, E | 1 |
| Ambellan, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Study of a New Medical Device for Oral Mucositis (MDOM Trial)[NCT05104268] | Phase 1/Phase 2 | 100 participants (Anticipated) | Interventional | 2021-11-30 | Not yet recruiting | ||
| A Phase 1/Phase 2 Study for the Prevention of Oral Mucositis (SPOM)[NCT05338398] | Phase 1/Phase 2 | 100 participants (Anticipated) | Interventional | 2022-04-15 | Enrolling by invitation | ||
| Phase I Study of Multiple Ascending Dose, to Investigate the Safety and Tolerability of the Use of Copaiba in Patients With Oral Cancer Submitted to Radiotherapy[NCT05308732] | Phase 1 | 36 participants (Anticipated) | Interventional | 2021-05-11 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for fluorouracil and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms | 2006 |
Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms | 2006 |
Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms | 2006 |
Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms | 2006 |
Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms | 2006 |
Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms | 2006 |
Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms | 2006 |
Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms | 2006 |
Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms | 2006 |
Survival in patients with intermediate or high grade non-Hodgkin's lymphoma: meta-analysis of randomized studies comparing third generation regimens with CHOP.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin | 2001 |
Current progress in the management of cancer. A collective review.
Topics: Adenocarcinoma; Angiography; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Cell Division; Chem | 1969 |
11 trials available for fluorouracil and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
MACOP-B vs F-MACHOP regimen in the treatment of high-grade non-Hodgkin's lymphomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Cyclophospha | 1995 |
High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multicenter s
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1996 |
Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1996 |
Autologous stem cell transplantation for aggressive non-Hodgkin's lymphomas in first complete or partial remission: a retrospective analysis of the outcome of 52 patients according to the age-adjusted International Prognostic Index.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclop | 1998 |
Clinical implications of serum levels of soluble CD30 in 70 adult anaplastic large-cell lymphoma patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cyta | 1998 |
How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens (MACOP-B and F-MACHOP) fare in the long-term?
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cyta | 1999 |
F-MACHOP in advanced aggressive lymphoma.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Do | 1992 |
MACOP-B vs F-MACHOP in the treatment of high-grade non-Hodgkin's lymphomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cyclophosphamide; Cyt | 1991 |
The F-MACHOP sequential combination chemotherapy regimen in advanced diffuse aggressive lymphomas: long-term results.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Protocols; Cyclophospham | 1991 |
[Mitoxantrone containing multi-drug chemotherapy in the management of malignancies. Collaborative Group for Clinical Trial of Mitoxantrone].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Digestive System Neoplasms; | 1989 |
Combined radiotherapy and chemotherapy of lymphomas and other cancers.
Topics: Clinical Trials as Topic; Cyclophosphamide; Dactinomycin; Fluorouracil; Follow-Up Studies; Hematopoi | 1971 |
41 other studies available for fluorouracil and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
Induction of apoptosis of azurin synthesized from P. aeruginosa MTCC 2453 against Dalton's lymphoma ascites model.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Pro | 2011 |
EFFECT OF CORTICOSTEROIDS ON RIBONUCLEASE AND NUCLEIC ACID CONTENT IN LYMPHOSARCOMA P1798.
Topics: Adrenal Cortex Hormones; Animals; Edetic Acid; Fluorouracil; Glucocorticoids; Lymphoma; Lymphoma, No | 1963 |
STUDIES ON TUMOR RESISTANCE TO 5-FLUOROURACIL.
Topics: Animals; Carbon Isotopes; Carboxy-Lyases; Fluorouracil; Genetics; Lymphoma; Lymphoma, Non-Hodgkin; M | 1963 |
GROWTH INHIBITION OF A SPECTRUM OF TRANSPLANTED MOUSE TUMORS BY COMBINATIONS OF INHIBITORS OF NUCLEIC ACID BIOSYNTHESIS AND ALKYLATING AGENTS.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Azaguanine; Azaserine; Carcinoma, Ehrlich Tumor; | 1963 |
METHODOLOGY OF PRELIMINARY CHEMOTHERAPEUTIC TRIALS IN PATIENTS WITH MALIGNANT SOLID TUMORS.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Bronchial Neoplasms; Colonic Neoplasms; Cyclophosp | 1963 |
CHEMOTHERAPEUTIC STUDIES WITH OSTEOGENIC SARCOMA HE10734.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Carcinoma, Hepatocellular; Fl | 1964 |
EXPERIENCE WITH CHEMOTHERAPY OF CANCER AT THE UNIVERSITY OF PRETORIA.
Topics: Antineoplastic Agents; Aziridines; Breast Neoplasms; Cyclophosphamide; Dactinomycin; Fluorouracil; H | 1964 |
NONSURGICAL TREATMENT OF PULMONARY CANCER.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Adrenal Cortex Hormones; Alkylating Agents; Antineoplastic Agen | 1964 |
TREATMENT OF MALIGNANT TUMOURS WITH 5-FLUOROURACIL IN 80 PATIENTS.
Topics: Biomedical Research; Breast Neoplasms; Colonic Neoplasms; Drug Therapy; Esophageal Neoplasms; Female | 1964 |
PROTRACTED AMBULATORY INFUSION CANCER CHEMOTHERAPY BY THE WATKINS CHRONOMETRIC INFUSOR.
Topics: Adenoma; Antineoplastic Agents; Breast Neoplasms; Carcinosarcoma; Colonic Neoplasms; Dermatitis, Exf | 1964 |
The use of G-CSF during first line chemotherapy adversely affects the yield of PBSC mobilization in non-Hodgkin's lymphoma patients.
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; | 2002 |
[Study on the concentration of FT-207 and 5-FU in serum, lymph nodes and tissues after administration of FT-207 suppositories].
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorouracil; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Mal | 1984 |
[Hematopoietic resistance to the damaging action of cytostatics in the occurrence of tumor drug resistance].
Topics: Animals; Daunorubicin; Drug Evaluation, Preclinical; Drug Resistance; Drug Therapy, Combination; Fla | 1981 |
Specific inhibition of pre-ribosomal RNA processing in extracts from the lymphosarcoma cells treated with 5-fluorouracil.
Topics: Animals; Base Sequence; Cell Division; Cell Nucleus; DNA, Ribosomal; Fluorouracil; Lymphoma, Non-Hod | 1994 |
Comparison of costs for infusion versus bolus chemotherapy administration: analysis of five standard chemotherapy regimens in three common tumors--Part one. Model projections for cost based on charges.
Topics: Antibiotics, Antineoplastic; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alky | 1996 |
Comparison of costs for infusion versus bolus chemotherapy administration--Part two. Use of charges versus reimbursement for cost basis.
Topics: Antibiotics, Antineoplastic; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alky | 1996 |
[Association of cancer and non-Hodgkin's lymphoma of the stomach].
Topics: Adenocarcinoma, Mucinous; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplast | 1996 |
Tolerability of the cytoprotective agent amifostine in elderly patients receiving chemotherapy: a comparative study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Amifostine; Antihypertensive Agents; Antineoplastic Com | 2001 |
Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
Topics: Animals; Carcinoma; Cell Line; Drug Resistance; Drug Therapy, Combination; Female; Fluorouracil; Leu | 1976 |
Evaluation of the ligation of the hepatic artery and regional arterial chemotherapy in the treatment of primary and secondary cancer of the liver.
Topics: Adolescent; Adult; Evaluation Studies as Topic; Female; Fluorouracil; Hepatic Artery; Humans; Ligati | 1975 |
[Effect of amphotericin B and its combination with 5-fluorouracil on the development of transplantable rat lymphosarcoma].
Topics: Amphotericin B; Animals; Drug Synergism; Drug Therapy, Combination; Female; Fluorouracil; Lymphatic | 1975 |
Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bleom | 1990 |
The F-MACHOP regimen in advanced diffuse aggressive lymphomas: summary of ten years' experience at a single institution.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Fluoroura | 1991 |
Clinical and pathological restaging in aggressive non-Hodgkin's lymphomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Fe | 1991 |
[Clinical efficacy of combined treatment in a late-stage malignant tumor of the head and neck].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; C | 1987 |
Combination chemotherapy for the treatment of diffuse aggressive lymphomas: F-MACHOP update.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dox | 1987 |
[Analysis of the course and treatment of primary non-Hodgkin's lymphoma of the gastrointestinal tract].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophospha | 1987 |
Sequential combination chemotherapy of high-grade non-Hodgkin's lymphoma with 5-fluorouracil, methotrexate, cytosine-arabinoside, cyclophosphamide, doxorubicin, vincristine, and prednisone (F-MACHOP).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cyclo | 1987 |
[Experimental and clinical studies on a sensitivity test of anticancer agents by 3H-thymidine autoradiography using a human malignant tumor transplanted to nude mice].
Topics: Adenocarcinoma; Aged; Animals; Antineoplastic Agents; Autoradiography; Cyclophosphamide; Drug Evalua | 1986 |
[Antimetastatic properties of aloe juice].
Topics: Aloe; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cyc | 1986 |
DNA flow cytometric study of 5-fluorouracil used to treat end stage non-Hodgkin's lymphoma.
Topics: Aged; DNA, Neoplasm; Female; Flow Cytometry; Fluorouracil; Humans; Interphase; Lymphoma, Non-Hodgkin | 1987 |
[Mitomycin alone and in therapeutic association in the palliative treatment of solid tumors].
Topics: Antineoplastic Agents; Breast Neoplasms; Cobalt Isotopes; Cyclophosphamide; Drug Combinations; Femal | 1971 |
Current problems in the use of the oncolytic drugs.
Topics: Antineoplastic Agents; Busulfan; Carcinoma, Squamous Cell; Child; Chlorambucil; Choriocarcinoma; Dac | 1968 |
In vitro estimate of sensitivity of individual human tumors to antitumor agents.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Arsenicals; Benzoates; Breast Neoplasms; Carbon Radi | 1974 |
Some determinants of drug responsiveness in bovine leukemia cells.
Topics: Animals; Antineoplastic Agents; Cattle; Cells, Cultured; Cytidine; Cytosine Nucleotides; Drug Resist | 1973 |
[Progress in chemotherapy of solid tumors and malignant lymphomas (continued)].
Topics: Adult; Antineoplastic Agents; Carcinoma; Choriocarcinoma; Female; Fluorouracil; Gonadal Steroid Horm | 1967 |
[On selection of antineoplastic agents for local use].
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Female; Fluorouracil; In Vitro Techniques; | 1969 |
Gastroscopic color photography in cancer chemotherapy.
Topics: Adenocarcinoma; Color; Cyclophosphamide; Fluorouracil; Follow-Up Studies; Gastroscopy; Humans; Lymph | 1970 |
Combination chemotherapy with L-asparaginase (EC-2) using P1798 lymphosarcoma.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Asparaginase; Azaserine; Cyclophosphami | 1971 |
Ribonuclease inhibitor in lymphosarcoma P1798: effects of steroid and 5-FU.
Topics: Animals; Fluorouracil; Glucocorticoids; Lymphoma, Non-Hodgkin; Mice; Neoplasms, Experimental; Ribonu | 1968 |
The role of ribonuclease in regression of lymphosarcoma P1798.
Topics: Animals; Chloromercuribenzoates; Chromatography; Corticosterone; Fluorouracil; Freezing; Hydrocortis | 1966 |